MXPA01003197A - Suministro enterico y colonico utilizando capsulas de chpm. - Google Patents

Suministro enterico y colonico utilizando capsulas de chpm.

Info

Publication number
MXPA01003197A
MXPA01003197A MXPA01003197A MXPA01003197A MXPA01003197A MX PA01003197 A MXPA01003197 A MX PA01003197A MX PA01003197 A MXPA01003197 A MX PA01003197A MX PA01003197 A MXPA01003197 A MX PA01003197A MX PA01003197 A MXPA01003197 A MX PA01003197A
Authority
MX
Mexico
Prior art keywords
enteric
hpmc capsules
colonic delivery
drug
hpmc
Prior art date
Application number
MXPA01003197A
Other languages
English (en)
Inventor
Robert Anthony Scott
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of MXPA01003197A publication Critical patent/MXPA01003197A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fertilizers (AREA)

Abstract

La invencion proporciona un sistema de suministro de droga para suministrar una droga a ya sea el intestino delgado (enterica) o el colon que comprende una capsula de CHPM que contiene la droga y en donde la capsula de CHPM se suministra con un recubrimiento adecuado de tal manera que la droga se libera a partir de la capsula ya sea en el intestino delgado o el colon.
MXPA01003197A 1998-09-28 1999-09-23 Suministro enterico y colonico utilizando capsulas de chpm. MXPA01003197A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10201798P 1998-09-28 1998-09-28
PCT/US1999/022117 WO2000018377A1 (en) 1998-09-28 1999-09-23 Enteric and colonic delivery using hpmc capsules

Publications (1)

Publication Number Publication Date
MXPA01003197A true MXPA01003197A (es) 2004-04-21

Family

ID=22287676

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01003197A MXPA01003197A (es) 1998-09-28 1999-09-23 Suministro enterico y colonico utilizando capsulas de chpm.

Country Status (14)

Country Link
US (1) US7094425B2 (es)
EP (1) EP1117386B1 (es)
JP (1) JP5068401B2 (es)
KR (1) KR100695562B1 (es)
CN (1) CN100358509C (es)
AT (1) ATE283689T1 (es)
AU (1) AU757343B2 (es)
CA (1) CA2344680C (es)
DE (1) DE69922394T2 (es)
ES (1) ES2234306T3 (es)
ID (1) ID28275A (es)
MX (1) MXPA01003197A (es)
PT (1) PT1117386E (es)
WO (1) WO2000018377A1 (es)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000774D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US7115565B2 (en) 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
WO2002076474A1 (en) 2001-03-27 2002-10-03 Pro-Pharmaceuticals, Inc. Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
US6645946B1 (en) 2001-03-27 2003-11-11 Pro-Pharmaceuticals, Inc. Delivery of a therapeutic agent in a formulation for reduced toxicity
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
DK1411900T4 (da) * 2001-06-01 2014-01-27 Pozen Inc Farmaceutiske sammensætninger til den koordinerede frigørelse af NSAIDs
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
EP1350507A1 (en) * 2002-04-04 2003-10-08 Applied NanoSystems B.V. Delivery of a substance to a pre-determinated site
DE60319822T2 (de) 2002-06-19 2009-06-04 Actogenix Nv Verfahren und mittel zur erhöhung der darmabsorption
US7485322B2 (en) * 2002-12-24 2009-02-03 Lek Pharmaceuticals D.D. Modified release pharmaceutical composition
US7825106B2 (en) 2003-09-03 2010-11-02 Agi Therapeutics Ltd. Modified release formulations and methods of treating inflammatory bowel disease
US7737133B2 (en) 2003-09-03 2010-06-15 Agi Therapeutics Ltd. Formulations and methods of treating inflammatory bowel disease
PL1883396T3 (pl) 2005-05-18 2014-03-31 Da Volterra Dostarczanie adsorbentów do okrężnicy
US20070082046A1 (en) * 2005-10-11 2007-04-12 Banner Pharmacaps, Inc. Enteric valproic acid
EP3097924B1 (en) 2005-11-29 2020-01-08 Intrexon Actobiotics NV Induction of mucosal tolerance to gliadin
WO2007070052A2 (en) * 2005-12-14 2007-06-21 Oxthera, Inc. Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
ATE499111T1 (de) * 2005-12-16 2011-03-15 Oxthera Inc Zusammensetzungen und verfahren zur oxalatreduktion
US20070148248A1 (en) * 2005-12-22 2007-06-28 Banner Pharmacaps, Inc. Gastric reflux resistant dosage forms
EP1965774A2 (en) * 2005-12-30 2008-09-10 Cogentus Pharmaceuticals, Inc. Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
SE0600091L (sv) 2006-01-18 2007-04-17 Bows Pharmaceuticals Ag Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin
US8048413B2 (en) 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
CN101595133B (zh) 2006-10-27 2012-11-14 比利时胶囊公司 羟丙基甲基纤维素硬胶囊及制备方法
DK3351268T3 (da) 2007-01-25 2020-11-02 Intrexon Actobiotics Nv Behandling af immunsygdom ved mukosal indgivelse af antigener
US9114071B2 (en) 2007-04-04 2015-08-25 Sigmoid Pharma Limited Oral pharmaceutical composition
IT1393245B1 (it) * 2008-07-24 2012-04-12 Universita' Degli Studi Di Milano Forme farmaceutiche per il rilascio tempo-specifico di farmaci
WO2010027498A2 (en) * 2008-09-03 2010-03-11 New Science Holdings, Llc Compositions and methods for inducing satiety and treating non-insulin dependent diabetes emillitus, pre-diabetic symptoms, insulin resistance and related disease states and conditions
US9757346B2 (en) 2008-09-03 2017-09-12 Volant Holdings Gmbh Compositions and methods for treating insulin resistance and non-insulin dependent diabetes mellitus (type II diabetes)
WO2010029335A1 (en) 2008-09-09 2010-03-18 Astrazeneca Uk Limited Method for delivering a pharmaceutical composition to patient in need thereof
KR101053731B1 (ko) * 2008-10-21 2011-08-02 이문성 용해시간 조절형 장세척제 조성물의 제조방법
DE102009001636A1 (de) * 2009-03-18 2010-09-23 Henkel Ag & Co. Kgaa Bleichmittel mit verzögertem Bleichbeginn
EA201290026A1 (ru) 2009-06-25 2012-07-30 Астразенека Аб Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid)
EA021112B1 (ru) * 2009-06-25 2015-04-30 Поузен Инк. Способ лечения боли и/или воспаления у пациента, нуждающегося в аспириновой терапии
EP2283830A1 (en) 2009-07-23 2011-02-16 Actogenix N.V. Aqueous enteric capsule coating
KR101705204B1 (ko) 2009-09-11 2017-02-09 롯데정밀화학 주식회사 장용성 경질 캡슐용 수성 조성물, 장용성 경질 캡슐의 제조방법 및 장용성 경질 캡슐
CN104958298A (zh) 2009-09-18 2015-10-07 阿得罗公司 阿片样受体拮抗剂用于胃肠道疾病的用途
KR101708086B1 (ko) 2010-02-25 2017-02-17 에보니크 룀 게엠베하 제약 또는 기능식품 제제
US9782354B2 (en) 2010-08-25 2017-10-10 II Grant Rufus Sparling Enteric active substance delivery
EP2722104B1 (en) 2010-10-26 2018-03-07 Capsugel Belgium NV Bulk Enteric Capsule Shells
KR101747211B1 (ko) * 2010-11-19 2017-06-14 롯데정밀화학 주식회사 장용성 경질 캡슐용 조성물 및 상기 조성물을 사용하여 제조된 장용성 경질 캡슐
CA3136084A1 (en) 2011-06-01 2012-12-06 Intrexon Actobiotics Nv Polycistronic expression system for bacteria
US10653631B2 (en) 2011-09-07 2020-05-19 Roland SAUR-BROSCH Optimal colon targeting technology
EP2753310B1 (de) 2011-09-07 2021-03-24 Roland Saur-Brosch Formulierung zur kontrollierten freisetzung eines oder mehreren stoffe im verdauungstrakt eines säugetiers
JP6219836B2 (ja) 2011-11-09 2017-10-25 キャプシュゲル・ベルジウム・エヌ・ヴィ 耐酸性ツーピースハードカプセル用の耐酸性バンディング溶液
WO2013101897A2 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
CN104302278B (zh) 2012-03-29 2018-08-21 塞拉拜姆有限责任公司 在回肠和阑尾上有活性的胃肠位点特异性口服接种疫苗制剂
CN103355656B (zh) * 2012-04-01 2016-01-20 中国科学院大连化学物理研究所 一种益生菌微胶囊产品及其制备与应用
JP6397813B2 (ja) 2012-05-02 2018-09-26 キャプシュゲル・ベルジウム・エヌ・ヴィ ヒドロキシプロピルメチルセルロースアセテートスクシネート（ｈｐｍｃａｓ）の水性分散液
CN104661655A (zh) * 2012-07-23 2015-05-27 陶氏环球技术有限责任公司 用于硬质胶囊外壳的膜组合物
US20140066837A1 (en) 2012-07-26 2014-03-06 Ronald L. Moy Skin care compositions and methods
KR20150046310A (ko) * 2012-08-29 2015-04-29 샐릭스 파마슈티컬스 인코포레이티드 완화제 조성물 및 변비 및 관련 위장관 질병 및 증상 치료를 위한 방법
US20140141075A1 (en) 2012-11-21 2014-05-22 Warner Chilcott Company, Llc 5-aminosalicylic acid capsule formulation
WO2014120804A1 (en) * 2013-01-30 2014-08-07 University Of Miami Enteric coated nanoparticles for oral vaccine and drug delivery and methods of production and use thereof
WO2014152338A1 (en) 2013-03-14 2014-09-25 Kabadi Mohan Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
US20160256399A1 (en) 2013-11-04 2016-09-08 Capsugel Belgium Nv Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole
DK2946774T3 (da) * 2014-05-19 2020-05-25 Tillotts Pharma Ag Coatede kapsler med modificeret frigivelse
EP3028694B1 (en) 2014-12-02 2017-07-12 Capsugel Belgium NV Dosage form articles for delayed release
EP3566699A1 (en) 2015-11-10 2019-11-13 Capsugel Belgium NV Acid resistant banding or sealing solution for acid resistant two piece hard capsules
RU2760997C2 (ru) 2016-01-14 2021-12-02 Интрексон Актобиотикс Н.В. Композиции и способы для лечения диабета 1 типа
EP3504246B1 (en) * 2016-08-23 2020-07-22 Dow Global Technologies LLC Cellulose ether acetate phthalates
US10858663B2 (en) 2016-09-02 2020-12-08 Intrexon Actobiotics N.V. Genetically modified bacteria stably expressing IL-10 and insulin
SG11201901928SA (en) 2016-09-13 2019-04-29 Intrexon Actobiotics N V Mucoadhesive microorganism
US10561630B2 (en) 2016-10-25 2020-02-18 Glykon Technologies Group, Llc Hydroxycitric acid compounds and capsule liquid delivery
CA3069396A1 (en) 2017-07-11 2019-01-17 Qualicaps Co., Ltd. Enteric hard capsule
CA3098604A1 (en) * 2018-05-03 2019-11-07 M.W. Encap Limited Dosage forms for delivery of medicines to the lower gastrointestinal tract
CN112566668A (zh) 2018-06-22 2021-03-26 快力胶囊股份有限公司 肠溶性硬胶囊
EP3610862A1 (en) * 2018-08-14 2020-02-19 Apillet APS Novel oral composition
CN109528689B (zh) * 2018-12-24 2021-09-21 江苏辰星药业股份有限公司 一种肠溶缓释植物胶囊及其制备方法
WO2021059240A1 (en) 2019-09-27 2021-04-01 Intrexon Actobiotics Nv D/B/A Precigen Actobio Treatment of celiac disease
CN113164405B (zh) * 2020-07-22 2022-09-06 绍兴康可胶囊有限公司 羟丙甲纤维素空心胶囊
CN113164404B (zh) * 2020-07-22 2022-09-02 绍兴康可胶囊有限公司 肠溶羟丙甲纤维素空心胶囊
WO2022137265A1 (en) * 2021-10-18 2022-06-30 Nutra Grace Enteric coated hpmc based herbal oil capsule for treatment of irritable bowel syndrome
WO2023212749A2 (en) * 2022-04-29 2023-11-02 Novatek Therapeutics, Llc Black seed oil formulations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138013A (en) * 1976-08-27 1979-02-06 Parke, Davis & Company Enteric capsules
JPS61100519A (ja) * 1984-10-23 1986-05-19 Shin Etsu Chem Co Ltd 医薬用硬質カプセル
US5314696A (en) * 1991-06-27 1994-05-24 Paulos Manley A Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
JP3116602B2 (ja) * 1992-10-06 2000-12-11 シオノギクオリカプス株式会社 硬質カプセル
US5656290A (en) * 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
DE4329503A1 (de) * 1993-09-01 1995-03-02 Galenik Labor Freiburg Gmbh Pharmazeutische Präparate zur gezielten Behandlung von Morbus Crohn und Colitis Ulcerosa
GB9412394D0 (en) * 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
DE9414065U1 (de) * 1994-08-31 1994-11-03 Roehm Gmbh Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen
JP2959423B2 (ja) * 1994-12-01 1999-10-06 シオノギクオリカプス株式会社 カプセル用皮膜組成物
SG80553A1 (en) * 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
JP3185206B2 (ja) * 1995-07-20 2001-07-09 田辺製薬株式会社 消化管下部放出型被覆カプセル製剤
JPH10152431A (ja) * 1996-08-02 1998-06-09 Hisamitsu Pharmaceut Co Inc 経口製剤用カプセルと経口カプセル製剤
CN1088584C (zh) * 1996-08-02 2002-08-07 久光制药株式会社 口服制剂用胶囊及口服胶囊制剂

Also Published As

Publication number Publication date
DE69922394D1 (de) 2005-01-05
KR100695562B1 (ko) 2007-03-15
AU6261399A (en) 2000-04-17
ES2234306T3 (es) 2005-06-16
WO2000018377A1 (en) 2000-04-06
CA2344680A1 (en) 2000-04-06
CN100358509C (zh) 2008-01-02
EP1117386B1 (en) 2004-12-01
US7094425B2 (en) 2006-08-22
EP1117386A1 (en) 2001-07-25
US20010036473A1 (en) 2001-11-01
ATE283689T1 (de) 2004-12-15
CA2344680C (en) 2008-11-25
KR20010075395A (ko) 2001-08-09
PT1117386E (pt) 2005-04-29
ID28275A (id) 2001-05-10
JP5068401B2 (ja) 2012-11-07
AU757343B2 (en) 2003-02-20
CN1321085A (zh) 2001-11-07
DE69922394T2 (de) 2005-12-22
JP2002525314A (ja) 2002-08-13

Similar Documents

Publication Publication Date Title
MXPA01003197A (es) Suministro enterico y colonico utilizando capsulas de chpm.
US5525634B1 (en) Colonic drug delivery system
NZ239574A (en) Delayed release capsules having a permeable wall with a hole and containing fluid-expandable material which pushes out first an inert substance then a drug-containing material
ZA955741B (en) A novel drug delivery system
IL117706A0 (en) Powdered drug storage and delivery system
IN179089B (es)
SG80553A1 (en) Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
IL123813A0 (en) Drug delivery system for two or more active substances
MX9707685A (es) Vehiculo de insuflacion de liberacion controlada para medicamentos.
EP0919228A4 (en) CAPSULES FOR ORAL PREPARATIONS AND CAPSULE PREPARATIONS FOR ORAL ADMINISTRATION
MXPA03012041A (es) Sistema de administracion controlada de farmacos de retencion gastrica.
EP0225189A3 (en) Targeted enteral delivery system
EA200200126A1 (ru) Гидродинамически сбалансированная пероральная система доставки лекарства
DK0752877T3 (da) Stabiliseret sammensætning til oral indgift af peptider
ZA968715B (en) Stable pharmaceutical forms of administration containing parathyroid hormone.
EP0817655A4 (en) INTRAPULMONARY ADMINISTRATION OF HEMATOPOIETIC MEDICINE
DE60025264D1 (de) Dosierbehälter für pulverförmige medikamente
GB9925166D0 (en) A capsule based drug delivery system
ZA981775B (en) Pharmaceutical formulations containing poorly soluble drug substances
TH57760B (th) การลำเลียงยาสู่ลำไส้เล็กและลำไส้ใหญ่โดยใช้แคปซูลชนิด hpmc
TH57760A3 (th) การลำเลียงแบบเอนเทอริกและโคโลนิก โดยใช้แคปซูลชนิด hpmc
IT1269412B (it) Apparecchio distributore di farmaci
GB9708260D0 (en) Gas capsule and gas delivery system
GB9725422D0 (en) Control release formulations in softgel and two piece hard gelatine capsules for oral delivery of drug molecules
GB9508774D0 (en) Delivery of drugs etc.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees